Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Danova

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Oncology Reports|June 19, 2001
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II studyS Brugnatelli, A Riccardi, M Danova, et al.
Journal of Cellular Physiology|August 15, 2000
Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitroC Porta, M Danova, A M Orengo, et al.
Haematologica|May 1, 1996
Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donorsL Torretta, C Perotti, G Dornini, et al.
International Journal of Oncology|March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancerA Riccardi, C Tinelli, S Brugnatelli, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter studyP Antognoni, M Bignardi, L F Cazzaniga, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Cord blood in vitro expanded CD41 cells: identification of novel components of megakaryocytopoiesisA Balduini, M d'Apolito, D Arcelli, et al.
British Journal of Haematology|April 12, 2000
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycleC Lucotti, L Malabarba, V Rosti, et al.
Histopathology|November 26, 2003
Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case studyM Lucioni, E Boveri, R Rosso, et al.
British Journal of Cancer|March 30, 2006
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyC Bengala, C Zamagni, P Pedrazzoli, et al.
British Journal of Cancer|July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)A Riccardi, P Pugliese, M Danova, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Oncology Reports|June 19, 2001
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II studyS Brugnatelli, A Riccardi, M Danova, et al.
Journal of Cellular Physiology|August 15, 2000
Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitroC Porta, M Danova, A M Orengo, et al.
Haematologica|May 1, 1996
Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donorsL Torretta, C Perotti, G Dornini, et al.
International Journal of Oncology|March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancerA Riccardi, C Tinelli, S Brugnatelli, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter studyP Antognoni, M Bignardi, L F Cazzaniga, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Cord blood in vitro expanded CD41 cells: identification of novel components of megakaryocytopoiesisA Balduini, M d'Apolito, D Arcelli, et al.
British Journal of Haematology|April 12, 2000
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycleC Lucotti, L Malabarba, V Rosti, et al.
Histopathology|November 26, 2003
Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case studyM Lucioni, E Boveri, R Rosso, et al.
British Journal of Cancer|March 30, 2006
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyC Bengala, C Zamagni, P Pedrazzoli, et al.
British Journal of Cancer|July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)A Riccardi, P Pugliese, M Danova, et al.
Pageof 16